FDA Adds More Drugs To Valsartan Recall List
(CNN) — The US Food and Drug Administration again added to its list of products that are included in the recall of drugs containing valsartan, a generic ingredient that helps people with high blood pressure and heart failure. That ingredient in the recalled drugs was tainted with a possible carcinogen.
The FDA testing of these products determined that an additional lot of brands sold under the name RemedyRepack needed to be added to the recall list.
See The Full List Here (PDF)
Several pills that contain valsartan have been under a voluntary recall since July. The drugs were tainted with N-nitrosodimethylamine, or ND...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Valsartan Source Type: news
The FDA again adds more drugs to its valsartan recall list
The US Food and Drug Administration again added to its list of products that are included in the recall of drugs containing valsartan, a generic ingredient that helps people with high blood pressure and heart failure. That ingredient in the recalled drugs was tainted with a possible carcinogen. (Source: CNN.com - Health)
Source: CNN.com - Health - October 25, 2018 Category: Consumer Health News Source Type: news
Cost of blood pressure drug surges in U.S. after recall
Prices for two dosages of the blood pressure drug valsartan rose more than any other drug in the United States in September, following a recall of much of the drug's supply. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
EU places China's Zhejiang Huahai under increased supervision
European authorities are placing Zhejiang Huahai Pharmaceutical Co Ltd under higher supervision, the European Medicines Agency said on Monday, in the latest crackdown on the Chinese firm after a probable carcinogen was found in its blood pressure drug valsartan. (Source: Reuters: Health)
Source: Reuters: Health - October 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug? Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
Evidence suggests that sacubitril/valsartan may have antiarrhythmic effects. What does this mean for prevention of sudden death?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 8, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Diovan HCT (Valsartan and Hydrochlorothiazide) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 3, 2018 Category: Drugs & Pharmacology Source Type: news
FDA Freezes Imports From Chinese Maker of Tainted Valsartan FDA Freezes Imports From Chinese Maker of Tainted Valsartan
The FDA ' s import alert bans all ingredients and finished drug products made by Zhejiang Huahai Pharmaceuticals from legally entering the United States.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
FDA Bans Import of Meds From Chinese Firm
The 'import alert' from the FDA against Zhejiang Huahai Pharmaceuticals comes after a series of recalls for valsartan heart and blood pressure drugs that include ingredients made by ZHP. (Source: WebMD Health)
Source: WebMD Health - September 28, 2018 Category: Consumer Health News Source Type: news
Losartan vs. Valsartan (Differences between Side Effects and Uses)
Title: Losartan vs. Valsartan (Differences between Side Effects and Uses)Category: MedicationsCreated: 9/21/2018 12:00:00 AMLast Editorial Review: 9/21/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - September 21, 2018 Category: Drugs & Pharmacology Source Type: news
Safe to Start Sacubitril/Valsartan Predischarge in Acute HF Safe to Start Sacubitril/Valsartan Predischarge in Acute HF
In first of its kind data from the TRANSITION trial, patients safely tolerated the early-initiation strategy as well as the recommended practice of starting the uptitration process after discharge.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Regulators find second cancer-linked chemical in recalled drug
A closer inspection of valsartan, a commonly used blood pressure medication, has uncovered traces of a second toxin. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 17, 2018 Category: Pharmaceuticals Source Type: news
FDA Finds Another Carcinogen in Certain Valsartan Heart Meds
Title: FDA Finds Another Carcinogen in Certain Valsartan Heart MedsCategory: Health NewsCreated: 9/14/2018 12:00:00 AMLast Editorial Review: 9/17/2018 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - September 17, 2018 Category: Cardiology Source Type: news
Daily aspirin not beneficial in healthy adults
Trial looks at risks and benefits of aspirin Related items fromOnMedica Too few women take part in many CVD clinical trials US doctor says FDA should have withdrawn rosuvastatin GPs defend practice on prescribing statins Drugs regulators “put profits before patients” Withdrawn valsartan meds not linked to short-term cancer risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 17, 2018 Category: UK Health Source Type: news
FDA Finds Another Carcinogen in Certain Valsartan Heart Meds
FRIDAY, Sept. 14, 2018 -- The U.S. Food and Drug Administration warns that it has found a second impurity in three lots of Torrent Pharmaceuticals ' valsartan drug products.
The FDA first recalled valsartan medicines back in July, after the Chinese... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2018 Category: Pharmaceuticals Source Type: news
Second Contaminant Found in Valsartan Drugs
Those drugs were already part of August’s recall of valsartan products for possible contamination with NDMA, another impurity that may cause cancer. (Source: WebMD Health)
Source: WebMD Health - September 14, 2018 Category: Consumer Health News Source Type: news
